Aimmune Therapeutics [NASDAQ: AIMT] Signs Definitive Agreement With Nestle
Hasnain Khan
August 31, 2020
Aimmune Therapeutics, Inc. [NASDAQ: AIMT] disclosed today it has signed a definitive agreement with a wholly-owned subsidiary of Nestle S.A, Sociétés des Produits Nestlé S.A.